Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
Clinical trial NCT06154447 · COMPLETED
Trial details
- NCT number
- NCT06154447
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-12
- Primary completion
- 2026-07-10
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.